July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
A novel estrogen receptor GPER1 activation promote retinal ganglion cell survivor in normal tension glaucoma
Author Affiliations & Notes
  • Qinqin Deng
    Eye center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
  • Yiqiao Xing
    Eye center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
  • Mengnan Jiang
    Eye center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
  • Xueyun Ma
    Eye center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
    Urumqi City Ophthalmology and Otolaryngology Hospital, Urumqi, Xinjiang, China
  • Qingqing Zhao
    Eye center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
  • Wei Lu
    Eye center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
  • Xinlan Lei
    Eye center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
  • Ying Li
    Eye center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
  • Yin Shen
    Eye center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
  • Footnotes
    Commercial Relationships   Qinqin Deng, None; Yiqiao Xing, None; Mengnan Jiang, None; Xueyun Ma, None; Qingqing Zhao, None; Wei Lu, None; Xinlan Lei, None; Ying Li, None; Yin Shen, None
  • Footnotes
    Support  NSFC 81800872
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4855. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Qinqin Deng, Yiqiao Xing, Mengnan Jiang, Xueyun Ma, Qingqing Zhao, Wei Lu, Xinlan Lei, Ying Li, Yin Shen; A novel estrogen receptor GPER1 activation promote retinal ganglion cell survivor in normal tension glaucoma. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4855. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : G protein coupled estrogen receptor (GPER1) is a novel estrogen receptor (ER) located in the plasma membrane. The expression and functions of GPER1 in retina was largely unknown. In this project, we performed NMDA model to identity the potential functions of GPER1 in mouse retina.

Methods : Intravitreal injection of NMDA was performed to induce retinal ganglion cells (RGCs) damage. Subcutaneous administered of E2, GPER1 agonist (G-1) or antagonist (G-15) once a day for 14 days before NMDA injection. Immunofluorescence staining was performed to explore the survivor of RGCs and Müller cell gliosis. TUNEL staining was used to study the apoptosis. The molecular mechanism were detected via antibody microarray analysis.

Results : We firstly identified the expression of GPER1 in mouse retina, which mainly located in the ganglion cells layer (GCL) and inner nuclear layer (INL). Application of E2 or G-1 significantly increased the survivor of RGCs. E2+tamoxifen (TAM), estrogen receptor α and β (ERα and ERβ) antagonist, mimic the same protective effects, whereas E2+G-15 did not. Meanwhile, the TUNEL positive RGCs and GFAP expression were attenuated in E2 and G-1 groups. Application of the PI3K/Akt antagonist Ly294002 abolished the regulation of G-1. And the antibody microarray indicated the apoptosis modulators reducing: Bad, Caspase 3, Caspase 7, Smad2, P-53 and TAK1 in G-1 group. The similar modulation of G-1 was found in acute ocular hypertension (AOH) model.

Conclusions : Estrogen exhibited protective effects in mouse retina, which was modulated via novel estrogen receptor GPER1, but not classical receptors ERα and ERβ, indicating a potential therapy target of GPER1 in retina diseases.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×